Literature DB >> 30169026

Configurational and Conformational Equilibria of N6-(2-Deoxy-d-erythro-pentofuranosyl)-2,6-diamino-3,4-dihydro-4-oxo-5- N-methylformamidopyrimidine (MeFapy-dG) Lesion in DNA.

Stephanie N Bamberger1, Chanchal K Malik1, Markus W Voehler1, Summer K Brown1, Hope Pan1, Tracy L Johnson-Salyard1, Carmelo J Rizzo1, Michael P Stone1.   

Abstract

The most common lesion in DNA occurring due to clinical treatment with Temozolomide or cellular exposures to other methylating agents is 7-methylguanine (N7-Me-dG). It can undergo a secondary reaction to form N6-(2-deoxy-d-erythro-pentofuranosyl)-2,6-diamino-3,4-dihydro-4-oxo-5- N-methylformamidopyrimidine (MeFapy-dG). MeFapy-dG undergoes epimerization in DNA to produce either α or β deoxyribose anomers. Additionally, conformational rotation around the formyl bond, C5- N5 bond, and glycosidic bond may occur. To characterize and quantitate the mixture of these isomers in DNA, a 13C-MeFapy-dG lesion, in which the CH3 group of the MeFapy-dG was isotopically labeled, was incorporated into the trimer 5'-TXT-3' and the dodecamer 5'-CATXATGACGCT-3' (X = 13C-MeFapy-dG). NMR spectroscopy of both the trimer and dodecamer revealed that the MeFapy-dG lesion exists in single strand DNA as ten configurationally and conformationally discrete species, eight of which may be unequivocally assigned. In the duplex dodecamer, the MeFapy-dG lesion exists as six configurationally and conformationally discrete species. Analyses of NMR data in the single strand trimer confirm that for each deoxyribose anomer, atropisomerism occurs around the C5- N5 bond to produce R a and S a atropisomers. Each atropisomer exhibits geometrical isomerism about the formyl bond yielding E and Z conformations. 1H NMR experiments allow the relative abundances of the species to be determined. For the single strand trimer, the α and β anomers exist in a 3:7 ratio, favoring the β anomer. For the β anomer, with respect to the C5- N5 bond, the R a and S a atropisomers are equally populated. However, the Z geometrical isomer of the formyl moiety is preferred. For the α anomer, the E- S a isomer is present at 12%, whereas all other isomers are present at 5-7%. DNA processing enzymes may differentially recognize different isomers of the MeFapy-dG lesion. Moreover, DNA sequence-specific differences in the populations of configurational and conformational species may modulate biological responses to the MeFapy-dG lesion.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30169026      PMCID: PMC6352716          DOI: 10.1021/acs.chemrestox.8b00135

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  99 in total

1.  The two main DNA lesions 8-Oxo-7,8-dihydroguanine and 2,6-diamino-5-formamido-4-hydroxypyrimidine exhibit strongly different pairing properties.

Authors:  Matthias Ober; Uwe Linne; Johannes Gierlich; Thomas Carell
Journal:  Angew Chem Int Ed Engl       Date:  2003-10-20       Impact factor: 15.336

2.  Structural basis for the dual coding potential of 8-oxoguanosine by a high-fidelity DNA polymerase.

Authors:  Luis G Brieba; Brandt F Eichman; Robert J Kokoska; Sylvie Doublié; Tom A Kunkel; Tom Ellenberger
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

3.  Secondary Ph+ acute lymphoblastic leukemia after temozolomide.

Authors:  Serena De Vita; Silvia De Matteis; Luca Laurenti; Patrizia Chiusolo; Giovanni Reddiconto; Alessia Fiorini; Giuseppe Leone; Simona Sica
Journal:  Ann Hematol       Date:  2005-07-26       Impact factor: 3.673

Review 4.  Investigating the biochemical impact of DNA damage with structure-based probes: abasic sites, photodimers, alkylation adducts, and oxidative lesions.

Authors:  Heidi A Dahlmann; V G Vaidyanathan; Shana J Sturla
Journal:  Biochemistry       Date:  2009-10-13       Impact factor: 3.162

5.  Recognition of formamidopyrimidine by Escherichia coli and mammalian thymine glycol glycosylases. Distinctive paired base effects and biological and mechanistic implications.

Authors:  K Asagoshi; T Yamada; Y Okada; H Terato; Y Ohyama; S Seki; H Ide
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

6.  Isolation and structural characterization of a cDNA clone encoding the human DNA repair protein for O6-alkylguanine.

Authors:  K Tano; S Shiota; J Collier; R S Foote; S Mitra
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

7.  In vivo repair of methylation damage in Aag 3-methyladenine DNA glycosylase null mouse cells.

Authors:  S A Smith; B P Engelward
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

8.  Effects of a guanine-derived formamidopyrimidine lesion on DNA replication: translesion DNA synthesis, nucleotide insertion, and extension kinetics.

Authors:  Kenjiro Asagoshi; Hiroaki Terato; Yoshihiko Ohyama; Hiroshi Ide
Journal:  J Biol Chem       Date:  2002-02-11       Impact factor: 5.157

9.  Formation and stability of alkylated pyrimidines and purines (including imidazole ring-opened 7-alkylguanine) and alkylphosphotriesters in liver DNA of adult rats treated with ethylnitrosourea or dimethylnitrosamine.

Authors:  L Den Engelse; G J Menkveld; R J De Brij; A D Tates
Journal:  Carcinogenesis       Date:  1986-03       Impact factor: 4.944

Review 10.  Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke.

Authors:  S S Hecht; D Hoffmann
Journal:  Carcinogenesis       Date:  1988-06       Impact factor: 4.944

View more
  2 in total

1.  Processing of N5-substituted formamidopyrimidine DNA adducts by DNA glycosylases NEIL1 and NEIL3.

Authors:  Irina G Minko; Plamen P Christov; Liang Li; Michael P Stone; Amanda K McCullough; R Stephen Lloyd
Journal:  DNA Repair (Amst)       Date:  2018-11-05

2.  Kinetics of DNA Adducts and Abasic Site Formation in Tissues of Mice Treated with a Nitrogen Mustard.

Authors:  Haoqing Chen; Ziyou Cui; Leila Hejazi; Lihua Yao; Scott J Walmsley; Carmelo J Rizzo; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2020-04-02       Impact factor: 3.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.